These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26724555)

  • 1. The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgery.
    Leunissen TC; Janssen PW; Ten Berg JM; Moll FL; Korporaal SJ; de Borst GJ; Pasterkamp G; Urbanus RT
    Vascul Pharmacol; 2016 Feb; 77():19-27. PubMed ID: 26724555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of perioperative antiplatelet therapy and platelet reactivity testing in carotid revascularization: overview of the evidence.
    Leunissen TC; De Borst GJ; Janssen PW; ten Berg JM
    J Cardiovasc Surg (Torino); 2015 Apr; 56(2):165-75. PubMed ID: 25600432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge for predicting bleeding events by assessing platelet reactivity following coronary stenting.
    Choi SY; Kim MH; Serebruany V
    Int J Cardiol; 2016 Mar; 207():128-31. PubMed ID: 26800135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibition and bleeding complications in cardiac surgery: A review.
    Hansson EC; Jeppsson A
    Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel.
    Bonello L; Mancini J; Pansieri M; Maillard L; Rossi P; Collet F; Jouve B; Wittenberg O; Laine M; Michelet P; Bessereau J; Lemesle G; Dignat-George F; Paganelli F; Camoin-Jau L
    J Thromb Haemost; 2012 Oct; 10(10):1999-2005. PubMed ID: 22863374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Function Testing in Patients on Antiplatelet Medications.
    Gross L; Aradi D; Sibbing D
    Semin Thromb Hemost; 2016 Apr; 42(3):306-20. PubMed ID: 26886395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Reactivity: Is There a Role to Switch?
    Aradi D; Merkely B; Komócsi A
    Prog Cardiovasc Dis; 2015; 58(3):278-84. PubMed ID: 26260612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
    Mahla E; Tantry US; Prüller F; Gurbel PA
    Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.
    Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
    Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of platelet function testing in PCI and CABG patients.
    Janssen PW; ten Berg JM; Hackeng CM
    Blood Rev; 2014 May; 28(3):109-21. PubMed ID: 24745727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function testing and prediction of procedural bleeding risk.
    Grove EL; Hossain R; Storey RF
    Thromb Haemost; 2013 May; 109(5):817-24. PubMed ID: 23467639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer?
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    Thromb Haemost; 2015 Jan; 113(1):37-52. PubMed ID: 25231675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between point-of-care platelet function testing and bleeding after coronary angiography according to two different definitions for bleeding.
    Holm M; Tornvall P; Dalén M; van der Linden J
    Am J Cardiol; 2014 Nov; 114(9):1347-53. PubMed ID: 25220849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.
    Straub N; Beivers A; Lenk E; Aradi D; Sibbing D
    Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.